We are committed to developing Mariposa as a Welsh company, and our longer-term vision is to establish a dedicated science ...

Hovione, a global integrated specialist CDMO, and Industrial Design Consultancy Ltd (IDC), an international product ...

For Jake Becraft, Ph.D., the future of America’s biomedical innovation isn’t just playing out in the lab—it's being shaped by ...

Artificial intelligence has already made its mark in commercial industries, and there's a good argument to be made that AI is ...

LTS LOHMANN Therapie-Systeme AG ("LTS"), a leading pharmaceutical technology company specializing in advanced drug delivery systems, today ...

With Ireland’s trifecta of stability, regulation, and talent, it is poised to deliver a €200 billion ecosystems opportunity ...

Biosimilar formulation development requires navigating around scientific, regulatory, and legal challenges, according to Sung ...

Switzerland's DINAMIQS receives Swissmedic approval for GMP viral vector production, becoming the country's first fully ...

CLEVELAND, May 13, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today reported financial results for the first quarter of 2026, highlighting commercial momentum for ZEVASKYN.

Successful partnership continues as bispecific antibody candidate moves to GMP manufacturing; project highlights Japan's advanced capabilities in bioprocessing and AGC Biologics' expanding global ...

MilliporeSigma supports the commercialization of Genetix Biotherapeutics' FDA-approved gene therapies.

Michael Wang, co-chief executive officer of Ispire Technology Inc. Michael, you may begin. Michael Wang: Thank you, operator, ...